IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Discovery of gene limiting replication of HIV published in Nature

August 2, 2023

New study of nearly 4,000 people of African ancestries led to identification of gene inhibiting HIV replication.

Read more

ADVANCE

ADVANCE (Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic) is a 5-year cooperative agreement extended through June 2026 with the U.S. Agency for International Development (USAID), through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

Read more

Podcasts

Impact Voices Episode 3: Progress & Passion Driving HIV Vaccine Research

July 25, 2023

Progress & Passion Driving HIV Vaccine Research: NICD's Perspective In this episode, William Dekker, a Communication Specialist at IAVI, engages in a thoughtful conversation with Thandeka Moyo-Gwete, Ph.D., and Dale Kitchin, Ph.D., both distinguished senior scientists at the National Institute for Communicable Diseases (NICD) in South Africa. In recognition of HIV Vaccine Awareness Day (HVAD), this dialogue delves into the essential role of HIV vaccines and the continuous pursuit of research and development for a safe and effective vaccine against HIV. Both Thandeka and Dale offer insights into what fuels their dedication and the substantial efforts their team is making to propel the field of HIV vaccine research forward.

Read more

Scientific Publications

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda

Read more

Features

Join IAVI at the 2023 International AIDS Conference!

July 17, 2023

Taking place in Brisbane, Australia, this International AIDS Society (IAS) conference features the latest scientific research for progress against the HIV epidemic.

Read more

Press Releases

Germany issues award to IAVI to support development of the MTBVAC tuberculosis vaccine candidate

July 6, 2023

NEW YORK — JULY 6, 2023 — IAVI is pleased to announce a new award has been granted by the German government to help support the late-stage development of a promising tuberculosis (TB) vaccine candidate, MTBVAC. The German Federal Ministry of Education and Research (BMBF) through the KfW Development Bank has committed to contribute €9.2…

Read more

Features

IAVI welcomes Germany to its list of generous supporters and recognizes the German government as a steadfast advocate and active participant in global health initiatives

July 6, 2023

Germany commits to 9.2 million Euros for the next five years to support development of a safe, effective, affordable, and accessible tuberculosis vaccine.

Read more

IAVI Report

Hitchhiking the mucosa

July 6, 2023

Brittany Hartwell and her lab are exploring new ways to transport vaccine antigens across mucosal barriers to trigger more protective immune responses against many pathogens, including HIV.

Read more